PNL2 melanocytic marker in immunohistochemical evaluation of primary mucosal melanoma of the heap and neck

Head and Neck

Volumn 30, Issue 6, 2008, Pages 771-775

  Morris, Luc G ^a   Wen, Yong Hannah ^b   Nonaka, Daisukl ^b   DeLacure, Mark D ^a   Kutler, David I ^a   Huan, Youming ^c   Wang, Beverly Y ^b  

^a NEW YORK UNIVERSITY   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Immunohis tochemistry; Melanoma; Monoclonal antibody; Mucosal melanoma; PNL2

Indexed keywords

CELL MARKER; MELAN A; MICROPHTHALMIA ASSOCIATED TRANSCRIPTION FACTOR; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY HMB 45; MONOCLONAL ANTIBODY PNL 2; PROTEIN S 100;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEAD AND NECK CANCER; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MELANOCYTE; MELANOMA; NASOPHARYNX CANCER; NOSE CAVITY CANCER; PARANASAL SINUS CANCER; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY;

AGED; AGED, 80 AND OVER; ANTIBODIES, MONOCLONAL; ANTIBODIES, NEOPLASM; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MELANOMA; MIDDLE AGED; NASAL MUCOSA; NOSE NEOPLASMS; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 46249096366     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.20785     Document Type: Article

References (8)

1. Ballantyne AJ. Malignant melanoma of the skin of the head and neck. Analysis of 405 cases. Am J Surg 1970;120:425-431.
2. Batsakis JG, Regezi JA, Solomon AR. The pathology of head and neck tumors: mucosal melanomas. Head Neck Surg 1982;4:404-418.
3. Chang AE, Karnell LH, Menck HR. The National Cancer Data Base report on cutaneous and noncutaneous melanoma: a summary of 84,836 cases from the past decade. The American College of Surgeons Commission on Cancer and the American Cancer Society. Cancer 1998;83:1668-1678.
4. Chiu NT, Weinstock MA. Melanoma of oronasal mucosa: population-based analysis of occurrence and mortality. Arch Otolaryngol Head Neck Surg 1996;122:985-988.
5. Thompson LDR, Wienecke JA, Miettinen M. Sinonasal tract and nasopharyngeal melanomas: a clinicopathologic study of 115 patients with a proposed staging system. Am J Surg Pathol 2003;27:594-611.
6. Sheffield MV, Yee H, Dorvault CC, Weilbaecher KN, et al. Comparison of five antibodies as markers in the diagnosis of melanoma in cytologic preparations. Am J Clin Pathol 2002;118:930-936.
7. Busam KJ, Kucukgul D, Sato E, Frosina D, Teruya-Feldstein J, Jungbluth AA. Immunohistochemical analysis of novel monoclonal antibody PNL2 and comparison with other melanocyte differentiation markers. Am J Surg Pathol 2005;29:400-406.
8. Rochaix P, Lacroix-Triki M, Lamant L, Pichereaux C, et al. PNL2, a new monoclonal antibody directed against a fixative-resistant melanocyte antigen. Mod Pathol 2003; 16:481-490.